Dysregulation and detection methods of EGFR in oral cancer. A narrative review.

Dysregulation and detection methods of EGFR in oral cancer. A narrative review.

Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein, with an intracellular domain and tyrosine kinase function (TK) involved in cell proliferation. Dysfunctions in EGFR signaling pathways have been associated with oral malignant tumors such as oral squamous cell carcinoma (OSCC)....

Full description

Bibliographic Details
Main Authors:	Carolina Somarriva, Alejandra Fernández, Jorge Candia, Javier Campos, Daniela Albers, Jorge Briceño
Format:	Article
Language:	English
Published:	Universidad de Concepción. 2016-11-01
Series:	Journal of Oral Research
Subjects:	Epidermal Growth Factor Receptor Mouth Neoplasm Mutation.
Online Access:	http://www.joralres.com/index.php/JOR/article/view/270/260

Similar Items

Difference in EGFR expression and mean vascular density in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma.
by: Alejandra Fernández, et al.
Published: (2017-02-01)

Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
by: Fan YANG, et al.
Published: (2011-08-01)

Influence of Immunohistochemistry Scoring Criteria in Detecting EGFR Mutations
by: Xin FENG, et al.
Published: (2015-12-01)

EGFR Gene Mutation Statuses in Advanced Non-small Cell Lung Cancer Patients and Their Influence on Effect of Gefitinib
by: Wei ZHONG, et al.
Published: (2012-09-01)

Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer
by: Hui ZHANG, et al.
Published: (2017-01-01)

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01)

Analysis of the Efficacy of Immunotherapy on the Posterior Lines  of Advanced EGFR Mutant Patients with Non-small cell Lung Cancer
by: Li MA, et al.
Published: (2021-05-01)

Immunohistochemical detections of EGFR status in NSCLC
by: Jie WANG, et al.
Published: (2015-04-01)

Progress of Immunotherapy in EGFR-mutated Advanced Non-small Cell Lung Cancer
by: Yaoyao LIU, et al.
Published: (2023-12-01)

Detection and Analysis of EGFR and KRAS Mutations  in the Patients with Lung Squamous Cell Carcinomas
by: Hui ZHANG, et al.
Published: (2015-10-01)

Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer
by: Wensheng ZHOU, et al.
Published: (2020-02-01)

Detection and Its Clinical Significance of EGFR Gene Mutation and Gene Amplification in 187 Patients with Non-small Cell Lung Cancer
by: Qinghua ZHOU, et al.
Published: (2009-12-01)

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
by: Seo Yun Kim, M.D., et al.
Published: (2019-01-01)

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer
by: Rong WANG, et al.
Published: (2022-03-01)

Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review
by: Yingying Jiang, et al.
Published: (2023-05-01)

Chinese Expert Consensus on Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2023 Edition)
by: Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
Published: (2023-05-01)

EGFR Mutation Status in Uighur Lung Adenocarcinoma Patients
by: Li SHAN, et al.
Published: (2013-02-01)

Comparison of EGFR and KRAS Status between Primary Non-small Cell Lung Cancer and Corresponding Metastases: A Systematic Review and meta-analysis
by: Chengbo HAN, et al.
Published: (2010-09-01)

TGF-ß alterations in oral squamous cell carcinoma. Narrative review.
by: Jorge Candia, et al.
Published: (2016-08-01)

First-line Treatment with Furmonertinib Mesylate in Lung Adenocarcinoma Patient  with EGFR Exon 20 Insertion Mutantion
by: Zhengguo LI, et al.
Published: (2024-03-01)

The Relationship between EGFR Mutations and Response and Prognosis of Tyrosine Kinase Inhibitors in Advanced Non-small-cell Lung Cancer
by: Xuebing LI, et al.
Published: (2008-04-01)

Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey
by: Sang Hwa Lee, et al.
Published: (2015-11-01)

Epidermal Growth Factor Receptor Mutations and Radiotherapy  in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01)

Advances in Treatment of Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
by: Xue YANG, et al.
Published: (2022-05-01)

How to Make the Choice in the Retreatment of EGFR-TKI for Advanced NSCLC Patients Who Benefited from Prior Gefitinib Therapy: the Original Drug or Switching to A Second EGFR-TKI?
by: Chuanhao TANG, et al.
Published: (2013-07-01)

Detection of EGFR Gene Mutations in 100 Non-small Cell Lung Cancer Clinical Samples by a Real-time Polymerase Chain Reaction Method Using Amplification Refractory Mutation System Specific Primers and Taqman Fluorescence Probes
by: Jing ZHAO, et al.
Published: (2013-01-01)

A Real-world Study on the Expression Characteristics of PD-L1 in Patients  with Advanced EGFR Positive NSCLC and Its Relationship with the  Therapeutic Efficacy of EGFR-TKIs
by: Ran CHEN, et al.
Published: (2023-03-01)

CheckMate-722: The Rise and Fall of Nivolumab with Chemotherapy in TKI-Refractory EGFR-Mutant NSCLC
by: Lee ATM, et al.
Published: (2023-04-01)

Chemotherapy outcomes in EGFR‐TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study
by: Chien‐Yu Lin, et al.
Published: (2023-07-01)

Progress in Detection of EGFR Exon 20 Insertion Mutation and Targeted Therapies  in Non-small Cell Lung Cancer
by: Yulu WANG, et al.
Published: (2023-02-01)

Giant oral lipoma: a rare entity
by: José Burgos Ponce, et al.
Published: (2016-10-01)

CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?
by: Thiago David Alves PINTO, et al.
Published: (2021-06-01)

Detection and Clinical Significance of Abundance of EGFR Mutation
by: Yi SHAO, et al.
Published: (2017-08-01)

Results of EGFR Mutations Detected in Pleural Effusion and Its  Clinical Significance in 132 Patients with Advanced Non-small Cell Lung Cancer:  A Retrospective Study in A Single Center
by: Tao LU, et al.
Published: (2020-12-01)

Structural Analysis of Interactions between Epidermal Growth Factor Receptor (EGFR) Mutants and Their Inhibitors
by: Yingzhe Guo, et al.
Published: (2023-03-01)

Detection of EGFR and COX-2 Expression by Immunohistochemical Method on a Tissue Microarray Section in Lung Cancer and Biological Significance
by: Xinyun WANG, et al.
Published: (2010-02-01)

Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI
by: Yi SHAO, et al.
Published: (2020-05-01)

Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy  in Advanced NSCLC Patients with EGFR Mutations
by: Minjiang CHEN, et al.
Published: (2019-02-01)

Research Progress of Angiogenesis Inhibitors Plus EGFR-TKI in EGFR-mutated  Advanced Non-small Cell Lung Cancer
by: Bowen LI, et al.
Published: (2022-08-01)

Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database
by: Guangsheng ZHU, et al.
Published: (2021-04-01)